日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Folylpolyglutamate synthetase mRNA G-quadruplexes regulate its cell protrusion localization and enhance a cancer cell invasive phenotype upon folate repletion

叶酸多聚谷氨酸合成酶mRNA G-四链体调节其细胞突起定位,并在叶酸补充后增强癌细胞的侵袭表型。

Michal Stark ,May Levin ,Igor Ulitsky ,Yehuda G Assaraf

Deciphering molecular mechanisms underlying chemoresistance in relapsed AML patients: towards precision medicine overcoming drug resistance

揭示复发性 AML 患者化疗耐药的分子机制:迈向精准医疗克服耐药性

May Levin, Michal Stark, Yishai Ofran, Yehuda G Assaraf

Surmounting Cytarabine-resistance in acute myeloblastic leukemia cells and specimens with a synergistic combination of hydroxyurea and azidothymidine

羟基脲与叠氮胸苷的协同作用克服急性髓系白血病细胞和标本中的阿糖胞苷耐药性

May Levin, Michal Stark, Bluma Berman, Yehuda G Assaraf

Lysosomotropic drugs activate TFEB via lysosomal membrane fluidization and consequent inhibition of mTORC1 activity

溶酶体趋化药物通过溶酶体膜流化激活 TFEB,从而抑制 mTORC1 活性

Benny Zhitomirsky, Anna Yunaev, Roman Kreiserman, Ariel Kaplan, Michal Stark, Yehuda G Assaraf

The JmjN domain as a dimerization interface and a targeted inhibitor of KDM4 demethylase activity

JmjN结构域作为二聚化界面和KDM4脱甲基酶活性的靶向抑制剂

May Levin, Michal Stark, Yehuda G Assaraf

Binding of a Smad4/Ets-1 complex to a novel intragenic regulatory element in exon12 of FPGS underlies decreased gene expression and antifolate resistance in leukemia

Smad4/Ets-1 复合物与 FPGS 外显子 12 中的新型基因内调控元件结合是白血病基因表达下降和抗叶酸抗性的基础

Shachar Raz, Michal Stark, Yehuda G Assaraf

Heterogeneous nuclear ribonucleoprotein H1/H2-dependent unsplicing of thymidine phosphorylase results in anticancer drug resistance

异质核糖核蛋白H1/H2依赖的胸苷磷酸化酶的失剪接导致抗癌药物耐药性。

Michal Stark,Eran E Bram, Martin Akerman, Yael Mandel-Gutfreund, Yehuda G Assaraf